FIELD: medicine.
SUBSTANCE: treatment of depression in the patients suffering from coronary heart disease is ensured by introduction of essential fatty acids or a related drug containing eicosanpentanoic acid ether or docosahexaenoic acid ether, either separately, or mixed in the developed effective doses.
EFFECT: improved cardioprotective and antidepressive action in the given group of patients.
45 cl
